Production (Stage)
REGENXBIO Inc.
RGNX
$10.35
$1.5016.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.08M | -51.19M | -59.60M | -52.99M | -63.33M |
| Total Depreciation and Amortization | 3.96M | 4.02M | 3.96M | 4.05M | 4.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.18M | 3.88M | 9.02M | 7.48M | 11.85M |
| Change in Net Operating Assets | 16.41M | 11.66M | 6.07M | -4.04M | -8.16M |
| Cash from Operations | 33.63M | -31.62M | -40.55M | -45.50M | -55.46M |
| Capital Expenditure | -1.02M | -1.08M | -326.00K | -474.00K | -557.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 45.77M | 41.35M | 50.58M | 206.00K | 13.74M |
| Cash from Investing | 44.74M | 40.27M | 50.26M | -268.00K | 13.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 457.00K | 38.00K | 644.00K | 192.00K | 132.90M |
| Repurchase of Common Stock | -510.00K | 0.00 | 0.00 | 0.00 | -910.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.74M | -7.78M | -11.50M | -9.64M | -11.26M |
| Cash from Financing | -5.79M | -7.74M | -10.86M | -9.45M | 120.73M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.58M | 909.00K | -1.15M | -55.21M | 78.45M |